In This Issue
ASTRO Report: Strut-Based Brachytherapy Yields Low Toxicity
Surgeons & Radiation Oncologists in Multi-Disciplinary Breast Cancer Care
APBI Gains Traction as Effective Therapy
BrachyBytes Editorial Advisory Board

Deanna Attai, M.D.

Robert Kuske, M.D.

Jay Reiff, Ph.D.

Dan Scanderbeg, Ph.D

Catheryn Yashar, M.D.

Vic Zannis, M.D.

Upcoming Events


October 28-31, 2012
Boston Convention and Exhibition Center
Boston, MA
Booth #7002

BEST Forum
The BEST Forum is a unique online resource featuring web-based presentations from APBI experts exploring the data for breast brachytherapy efficacy, safety and treatment. Visit to watch presentations, download slides and other supporting materails, and register for updates on future presentations.  

Become a Center of Excellence in APBI

Click here to learn about becoming a Center of Excellence and find ways to grow your APBI program by reaching out to referring physicians and women in the community.

Contact for more information.  
Follow-up Links

Past Issues
Cianna Medical
SAVI Sisters

Virginia Hospital Medical Center

American Society of Radiation Oncology
American Brachytherapy Society
General Surgery News

October 2012

ASTRO Report: Strut-Based Brachytherapy Yields Low Toxicity 

Robert Hong, MD

The largest toxicity study of patients who have received accelerated partial breast irradiation (APBI) with the SAVI applicator wasRobert Hong, MD presented by radiation oncologist Robert Hong, MD, at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO). Reporting on 515 patients, including 100 patients with four years of follow up, Dr. Hong concluded that SAVI showed excellent local control and had favorably low rates of complications such as seroma, hyperpigmentation and telangiectasia.

The data was drawn from the SAVI Collaborative Research Group, which includes over 1,000 patients from 14 sites across the U.S. and represents the largest subset of patients who have received APBI with the SAVI applicator.

Dr. Hong discusses the latest study from the SAVI Collaborative  Research Group, including how the results compare to other forms of breast brachytherapy and what they mean for the future of strut-based brachytherapy. Read more


ASTRO Posters on Strut-Based Brachytherapy

Correlating Toxicity with Dosimetry (Hong et al.)

Correlating Cosmesis with Dosimetry (Finkelstein et al.)

Partners in Care: Surgeons & Radiation Oncologists in Multi-Disciplinary Breast Cancer Care 

Mark Gittleman, MD

 Mark Gittleman, MD

The delivery of breast brachytherapy requires the cooperation of  multiple specialties, but perhaps none more so than surgery and radiation oncology. Every step of the process – from discussion of treatment options to device selection to treatment planning and scheduling – must be carefully coordinated among the two teams.

Breast surgeon Mark Gittleman, MD, discusses the “dance” that takes place between surgeons and radiation oncologists, who should lead, and the importance of a team approach for a successful breast brachytherapy program. Read more

 ABS Logo

Watch Dr. Gittleman’s presentation, Patient Discussion: The Dance Between Surgeon and Radiation Oncologist, from the 2012 ABS Breast Brachytherapy School

Partial Breast Irradiation Gains Traction as Effective Therapy 

Accelerated partial breast irradiation (APBI) may be as effective as whole breast irradiation (WBI) for the prevention of local recurrence, according to research presented at the 2012 meeting of the American Society of Breast Surgeons (ASBrS; Ann Surg Oncol 2012 Jul 27. [Epub ahead of print]).

“I guess this is particularly timely, since there have been a few articles that are showing some controversy in APBI,” said Peter Beitsch, MD, director of the Dallas Breast Center. Read article